TSH Biopharm Corporation Limited

TPEX:8432 Stock Report

Market Cap: NT$2.5b

TSH Biopharm Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Sze-Yuan Yang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.8yrs
CEO ownershipn/a
Management average tenure4.6yrs
Board average tenure1.1yrs

Recent management updates

Recent updates

Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Feb 18
Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

Jan 21
Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Dec 16
TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

CEO Compensation Analysis

How has Sze-Yuan Yang's remuneration changed compared to TSH Biopharm's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

NT$88m

Mar 31 2024n/an/a

NT$92m

Dec 31 2023n/an/a

NT$62m

Sep 30 2023n/an/a

NT$54m

Jun 30 2023n/an/a

NT$55m

Mar 31 2023n/an/a

NT$53m

Dec 31 2022n/an/a

NT$62m

Sep 30 2022n/an/a

NT$68m

Jun 30 2022n/an/a

NT$60m

Mar 31 2022n/an/a

NT$57m

Dec 31 2021NT$6mNT$4m

NT$47m

Sep 30 2021n/an/a

NT$47m

Jun 30 2021n/an/a

NT$53m

Mar 31 2021n/an/a

NT$48m

Dec 31 2020NT$6mNT$5m

NT$62m

Compensation vs Market: Insufficient data to establish whether Sze-Yuan's total compensation is reasonable compared to companies of similar size in the TW market.

Compensation vs Earnings: Sze-Yuan's compensation has been consistent with company performance over the past year.

CEO

Sze-Yuan Yang

5.8yrs

Tenure

NT$5,724,000

Compensation

Ms. Sze-Yuan Yang serves as General Manager at TSH Biopharm Corporation Limited since January 17, 2019. She studied at Institute of Pharmacology, National Yangming University. She has served at TTY Pharmac...

Leadership Team

NamePositionTenureCompensationOwnership
Sze-Yuan Yang
General Manager5.8yrsNT$5.72mno data
Xin-Yang Liu
Vice General Manager of General Administration4.6yrsNT$3.07mno data
Jung-Liang Kao
Chief Financial Officerless than a yearno datano data
Chen-Ju Kan
Senior Manager of the Accounting Departmentno datano datano data
Jian-Rong Huang
Sales Division Director4.6yrsno datano data
Hsin-Young Liu
Company Secretary4.5yrsno datano data

4.6yrs

Average Tenure

Experienced Management: 8432's management team is considered experienced (4.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Chuan-Quan Lin
Chairman4.5yrsno datano data
Kang-Chi Chou
Representative Director4.5yrsno datano data
Carl Hsiao
Representative Director4.5yrsno data0.088%
NT$ 2.2m
Rwei-Syun Chen
Independent Directorno datano datano data
Yaw-Bin Huang
Independent Directorno datano datano data
Te-Yu Chou
Independent Director1.1yrsno datano data
Yong-Liang Wu
Director1.1yrsno datano data
Yuen-Liang Lai
Independent Directorless than a yearno datano data
Shiow-Ming Wu
Independent Directorless than a yearno datano data

1.1yrs

Average Tenure

Experienced Board: 8432's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.